JIRC international collaborators

The center has collaboration with the following international research groups and institutions.

Ralph Adams, Max-Planck Institute, Muenster

Peter Andersen, Else Marie Agger and Morten Ruhwald, Statens Serum Institute, Denmark

Annika Bergquist and Niklas Gjorkstrom, Karolinska University Hospital, Stockholm, Sweden

Eric A. Biessen, University Hospital Maastricht, Netherlands

Richard Blumberg, Brigham and Women’s Hospital, Harvard Medical School, Boston, US

Matthew Brown, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Australia

Kenneth Caidahl,  Karolinska Institute, Stockholm, Sweden

Mary Carrington, Center for Cancer Research, National Institute of Health, US

Marco Conti, University of California, San Francisco, US

Department of Medical Microbiology and Virology, University of the Free State, South Africa

Mikael Elofsson, MIMS, Umeå, Sweden

Sven Enerbäck, Gothenburg University, Sweden

Peter Garred, Copenhagen, Denmark

Daniel Gotthardt, University Hospital of Heidelberg, Germany

Bodo Grimbacher, Freiburg University, Germany

Hakon Hakonarson, Center for Applied Genomics and Department of Pediatrics, The Children’s Hospital of Philadelphia, US

Gøran Hansson, Karolinska Institutet, Stockholm, Sweden

Albert Heck, The Netherlands Proteomics Centre, Utrecht, The Netherlands

Friedrich Herberg, Universität Kassel, Germany

Bert van den Heuvel, Nijmegen, The Netherlands

Gideon Hirschfield, Centre for Liver Research, NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, UK, University

Pietro Invernizza and Ana Lleo, IRCSS Instituto Clinico Humanitas, Milan, Italy

Arthur Kaser, Department of Medicine, University of Cambridge, Addenbrook’s Hospital, Cambridge, UK

Martin Knofler, University of Vienna, Austria

Markus Huber-Lang, Ulm, Germany

Joshua LaBaer, Arizona State University, Arizona, US

Riitta Lahesmaa, University of Turku, Finland

Eicke Latz, University of Bonn, Germany

Konstantinos Lazaridis, The Mayo Clinic, Rochester, US

Joe Lewis, Chemical Biology Unit, EMBL, Germany

Egil Lien, University of Massachusetts, Worcester, US

Javier Martin, Instituto de Parasitologia y Biomedicina Lopez-Neyra, CSIC, Spain

Kim Midwood, Oxford University, UK

MMH Hospital Zanzibar, Tanzania

Michel Moutschen, Liege, Belgium

Susanne Dam Nielsen, Rigshospitalet, Denmark

Bo Nilsson, Uppsala, Sweden

The Nordic Liver Transplant Group

Klaus Okkenhaug, Babraham Institute, Cambridge, US

Leonid Padyukov, Karolinska Institute, Sweden

Guillaume Pidoux, Université Paris Süd, Paris, France

Tatiana Petrova, Helsinki University, Finland

Stefan Pflanz, Merck Research labs (former DNAX), Palo Alto, US

Alberto Pugliese, Diabetes Research Institute Foundation, US

Harlan Robins, Divisions for Public Health and Human Biology, Fred Hutchinson Cancer Research Center, Seattle, US

Julio Saez-Rodrigues, EMBL-EBI, Hinxton, UK

Stefan Schreiber and Andre Franke, Institute for Clinical and Molecular Biology, Christian-Albrechts University, Kiel, Germany

Ton N. Schumacher, Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

John D. Scott, University of Washington, Seattle, US

Chris Siebel, Genentech Inc, South San Francisco

Mario Strazzabosco and Luca Rabris, Liver Center, Yale University, New Haven, US and University of Padova, Italy

Anders Sonnerborg, Karolinska Institute, Sweden

Michael Trauner and Peter Fickert, Medical University of Vienna and Medical University of Graz, Austria

Johan Trowsdale, James Traherne and Vasilis Kosmoliaptsis, Cambridge Institute for Medical Research, Cambridge, UK

Krister Wennerberg, FIMM, Helsinki, Finland

Manuela Zaccolo, University of Oxford, UK

Lars Østergård, University of Aarhus, Denmark

Published Aug. 17, 2015 9:51 AM - Last modified Aug. 27, 2015 3:28 PM